Cite

HARVARD Citation

    Hashinokuchi, A. et al. (2022). Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma. Thoracic cancer. 13 (18), pp. 2624-2632. [Online]. 
  
Back to record